Accurate and timely cerebrospinal fluid (CSF) cell counts are critical in the diagnosis of meningitis, malignancy, demyelinating disease and hemorrhage. Due to historical limitations with the linearity of automated analyzers, CSF cell counts have traditionally been performed manually with a hemocytometer and the aid of a brightfield optical microscope. Manual cell counting is time-consuming, subjective due to reliance on human interpretation and requires a high degree of skill. This poses significant challenges for clinical laboratories of all sizes facing unprecedented staffing shortages. It also poses challenges for physicians who rely on timely results to provide appropriate patient management.
In this webinar, the featured speakers will discuss the importance of accurate and timely CSF cell counts and the positive impact of implementing a US Food and Drug Administration (FDA)-cleared advancement in CSF cell counting technology through case studies from three hospitals in the US, including MercyOne, Des Moines Medical Center.
Register for this webinar to develop a comprehensive understanding of the criticality of accurate and timely CSF cell counts and an automated solution designed to:
(1) free up tech time & improve result turnaround times,
(2) increase lab staff satisfaction & decrease stress levels, and
(3) eliminate errors associated with manual CSF cell counts & improve result accuracy.
Julie MacKenzie, MBA, Director, Clinical & Artel Product Portfolios, Advanced Instruments, LLC.
Julie MacKenzie, MBA, is Director for the Clinical & Artel Product Portfolios at Advanced Instruments, LLC. She has a Bachelor of Arts in Biochemistry, Cellular and Molecular Biology from Connecticut College and received her graduate degree from Boston College. Julie has 15 years of experience in the medical device space.
Brandon Haller, Clinical Applications Scientist, Advanced Instruments, LLC.
Brandon Haller is a Clinical Applications Scientist at Advanced Instruments, LLC. He has a Bachelor of Science in Microbiology from Montana State University and is an accredited Medical Laboratory Scientist (ASCP). Brandon has eight years of experience in clinical labs, and currently focuses on GloCyte Automated Cell and osmometer applications at Advanced Instruments.
Andrea Haynes, MLS (ASCP)CM, Laboratory Director, Hospital Services, MercyOne
Andrea Haynes, MLS, (ASCP)CM, is Laboratory Director, Hospital Services at MercyOne in Des Moines, IA. She has a Bachelor of Science in Clinical Laboratory Science/Medical Technology/Technologist from University of Iowa.
Jeff Tavares, M.Ed, Hematology Sales Specialist, Advanced Instruments, LLC.
Jeff Tavares, M.Ed, is a Hematologist Sales Specialist at Advanced Instruments, LLC. He has a Bachelor of Science in Speech-Language Pathology from Bridgewater State University and a Master’s in Education from American International College. Jeff has 9 years of experience in the medical device and pharma space. He currently focuses on managing the GloCyte Accounts for North America.
Who Should Attend?
- Chemistry Lab Supervisor
- Clinical Lab Manager
- Laboratory Director
- Medical Technologist
- Hematology Specialist
What You Will Learn
Attendees will develop a comprehensive understanding of:
- The importance of accurate and timely CSF cell counts for appropriate patient management
- An FDA-cleared advancement in CSF cell counting technology with linearity down to 0 cells/µL
- The positive impact of automating patient CSF cell counts through case studies
Advanced Instruments is a global company offering a novel portfolio of analytical tools including, OsmoTECH®, a robust line of micro-osmometers to support bioprocessing and quality control (QC), and Solentim, a portfolio of best in class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies.